City
Epaper

RDIF seeks Sputnik M vaccine registration for adolescents in India

By IANS | Updated: December 6, 2021 22:10 IST

New Delhi, Dec 6 The Russian Direct Investment Fund (RDIF) said on Monday that it has provided documents ...

Open in App

New Delhi, Dec 6 The Russian Direct Investment Fund (RDIF) said on Monday that it has provided documents to India's regulator for the registration of Sputnik M, the vaccine for adolescents aged 12-17.

"RDIF has provided India's regulator with documents for registration of Sputnik M - the vaccine for adolescents aged 12-17. Russia's Health Ministry registered Sputnik M on November 24. It has become a new member of the Sputnik vaccines family and is offered to international markets, joining Sputnik V and Sputnik Light," the RDIF said in a statement.

"Subject to the positive decision of India's authorities, Sputnik M could become the first registered vaccine for adolescents in the country and make an important contribution in protecting the younger population," the statement added.

The Sputnik V vaccine is already being used in India after it received emergency use authorisation in April 2021. Sputnik V is the first foreign-made vaccine to be used in India.

The RDIF is also working with India's regulatory authorities for the registration of Sputnik Light, the one shot vaccine based on human adenovirus serotype 26, as a standalone vaccine and a universal booster.

Partnering Dr. Reddy's Laboratories, RDIF has conducted additional clinical trials of Sputnik Light in India. The data from these trials have been presented to the Drugs Controller General of India (DCGI).

Kirill Dmitriev, the CEO of RDIF, said, "Russia and India joined forces since the beginning of the pandemic. A number of agreements with partners in India have helped RDIF significantly increase its production capabilities. We are ready to offer the Sputnik Light vaccine and the Sputnik M vaccine for adolescents to support strong herd immunity in India and continue saving millions of lives."

The RDIF has expressed hope that Sputnik Light could be successfully applied as a booster dose in partnership with the Serum Institute of India, which already produces the two vaccines.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Russian Direct Investment FundindiaNew DelhiHealth MinistryThe new delhi municipal councilDelhi south-westIndiUk-indiaKirill dmitrievRepublic of indiaIndia india
Open in App

Related Stories

National‘Harassing Crores for a Few’: Ex-CEC S.Y. Quraishi Criticises SIR Process at Lokmat National Conclave 2025

NationalLokmat National Conclave 2025: Manoj Jha Flags ‘Freebies Culture’, Says Elections Are No Longer Fair

HockeyIndia Clinches Bronze with 4-2 Win Over Argentina in FIH Men’s Junior Hockey World Cup (VIDEO)

CricketIndia vs South Africa 2025 Schedule: Full List of Matches, Dates, Venues and Fixtures

TechnologyOpenAI Offers ChatGPT Go Free for a Year in India; Check All the Features Users Can Now Access

Health Realted Stories

HealthAhmedabad Civil Medical College’s kidney institute sets national record with 500 transplants in 2025

HealthPatients falling ill from contaminated water in Indore rise to 66: MP Minister Vijayvargiya

HealthViral, Bacterial or Lifestyle Diseases? Know the Key Differences and Why It Matters

HealthDesk Job Health Hazards: Simple Daily Fixes to Protect Your Body and Mind

HealthHigh superbug load in Delhi environment posing public health risks: Study